Dallas Continues Momentum in Creating Life Science/Biotech Hub

Life Sciences and Biotech have long been target industries for the City of Dallas. The City’s support for development of biomedical and health research space was reinforced on June 14^th when Dallas City Council approved a $3M economic development grant, along with other incentives, for Bridge Labs. Bridge Labs will be the first institutional-quality, non-incubator space in the region that will feature 135K SF of research and development space along with lab suites for growth-stage life sciences entrepreneurs and companies. 

Bridge Labs expands the lab space currently offered at Pegasus Park, a 23-acre mixed-use office campus consisting of more than 750K SF of office and amenities space across multiple buildings located adjacent to the Dallas Design District and Medical District.   

“The things that are happening inside of these labs at Pegasus Park are changing the world” said Dallas City Councilman Omar Narvaez, at the Council meeting, “A whole compound has now been created and it is igniting this area that used to be desolate.” 

The life science ecosystem being created at Pegasus Park currently includes UT Southwestern, TAYSHA Gene Therapies, McKesson, Health Wildcatters, BioLabs Colossal, ReCode, etiraRX, and BioNTX.  Demolition is underway for Bridge Labs with an expected completion date of summer 2024.  The City’s investment in Bridge Labs better positions Pegasus Park and Dallas in its bid to be the site of the future national headquarters of National Institutes of Health’s Advanced Research Projects Agency for Health (ARPA-H).